Altasciences, a CRO/CDMO supporting all crucial steps in early-stage drug development, from lead candidate selection to clinical proof of concept, has completed the acquisition of Calvert Laboratories, a preclinical CRO located on the U.S. East Coast. This acquisition will complement Altasciences’ current preclinical West Coast operations, located just north of Seattle, WA. For more than 40 years, Calvert Laboratories has been working with clients to help develop the next generation of therapeutics aimed at extending and improving human life; in line with Altasciences’ focus on getting better drugs to the people who need them faster.
 
“This acquisition will increase small molecule expertise as well as add efficacy pharmacology, ophthalmology, and carcinogenicity study capabilities to Altasciences’ current preclinical offering,” said Steve Mason, co-chief operating officer, Altasciences. “Furthermore, it expands Altasciences’ presence on the East Coast, and the site is conveniently located in close proximity to our CDMO facility.”
 
Calvert Laboratories has a long track record in the industry as a collaborative development partner bringing extensive experience, an innovative solutions-oriented approach, and unsurpassed performance to preclinical drug development programs.
 
Michael Recny, outgoing CEO of Calvert Laboratories, said, “The entire team at Calvert Laboratories is very excited to join the Altasciences family. The company can now offer our clients an expanded suite of preclinical and clinical services by leveraging the broad capabilities of a larger and more diversified global CRO.”
 
Chris Perkin, CEO at Altasciences, said, “This acquisition is an integral part of Altasciences’ strategic growth plan to provide a comprehensive, fully integrated early phase drug development solution, while addressing the ever-changing outsourcing challenges of biopharmaceutical companies across the globe,” explained. We look forward to working side by side with our new team of preclinical experts on the East Coast, a team that shares our values for excellence, integrity, and customer focus.”